MYLK and urinary bladder carcinoma: Collectively, these results supported the idea that the MAP1A/miR-34a-5p/LINC0667/circ_MYLK/circ_MAP1B ceRNA network may play a role in the pathological processes of bladder cancer (Figure 8C).